It has hard to tease out whether this is a direct effect of the drug or simply due to decreased caloric (energy) intake
J Exp Clin Cancer Res (2022) 41(1):44
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing Even Though Medicare Cannot Cover The Drugs for Weight Loss A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years even though Medicare is explicitly prohibited by law from covering the drugs for obesity
van Ierssel, J., Osmond, M., Hamid, J., Sampson, M., & Zemek, R
In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing